Khales Payman, the President and CEO of Integer Holdings Corp, has reported new stock transactions involving the company's shares. This update is significant as it underscores the ongoing activity and transparency within the electromedical sector.
Integer Holdings Corp, identified by the Central Index Key 0001114483, operates in the electromedical and electrotherapeutic apparatus industry. The company is known for its innovative solutions in medical technology. Payman's recent filing, dated October 26, 2026, includes transactions that occurred on October 24, 2026.
According to the filing, Payman acquired a total of 3,504 shares of common stock through two transactions. The first transaction involved 2,514 shares, while the second transaction involved 990 shares purchased at a price of $126.54 each. Following these transactions, Payman now holds a total of 63,378 shares of common stock.
Additionally, Payman reported the acquisition of 2,514 restricted stock units, which are set to convert into common stock on a one-for-one basis. This indicates a strategic move to enhance his equity stake in the company, aligning his interests with those of shareholders.
The filing also notes that the reporting owner, Khales Payman, is both a director and an officer of Integer Holdings Corp. This dual role emphasizes the importance of executive ownership in the company's governance and decision-making processes.
Payman's transactions may have implications for both the company and its stakeholders, as they reflect confidence in Integer Holdings' future prospects. The electromedical industry is competitive, and such moves can signal to investors and analysts the leadership's commitment to the company's growth and stability.
Looking ahead, it remains to be seen if further filings will provide additional context regarding Payman's ongoing transactions or any strategic initiatives from Integer Holdings Corp. The filing does not specify what happens next.